GLP-1 receptor agonists have rapidly become a cornerstone of obesity and metabolic disease management, with widespread adoption across primary care, endocrinology, and specialized weight management practices. As utilization increases, clinicians are encountering a broader spectrum of comorbid gastrointestinal conditions, among which Helicobacter pylori (H. pylori) infection remains highly prevalent. This raises an important and increasingly
If you’ve ever lost weight only to regain it—sometimes more than you originally lost—you’re not alone. Research shows that the majority of people who lose weight through diet and exercise, with or without pharmacotherapy, regain most or all of it within five years. For decades, this pattern was blamed on lack of willpower or discipline.
Losing weight is serious business – it’s important for your health and self-image. The new “injectable” weight loss medications, semaglutide (Wegovy) and tirzepatide (Zepbound), and earlier pharmaceutical iterations, such as liraglutide (Saxenda), are safe, FDA-approved medications that can help people lose “amazing” amounts of weight (Weight Loss Medications Fairfax, VA – Weight Loss Pills Fairfax,
The short answer: creatine monohydrate is one of the best-studied supplements for strength and lean mass, but the benefit comes when it is paired with resistance training. No randomized trial has yet reported whether it protects muscle in people taking Zepbound, Wegovy or another GLP-1 medicine, so it is an option to discuss with your
In May 2025, the New England Journal of Medicine published the first head-to-head clinical trial comparing two of the most effective anti-obesity medications on the market: tirzepatide (Zepbound) and semaglutide (Wegovy). This was the phase 3b open label extension of the SURMOUNT-5 clinical trial involving 751 non-diabetic obese patients. The main finding was that tirzepatide led to significantly more weight loss than semaglutide over 72
